Sinopharm Launching Spike Protein Based mRNA Gene Serum Injection

Two billion dose production capacity per year. Will this be approved for export?

Previous on topic:

BREAKING: China's Sinopharm Deploying mRNA Kill Shots

But there was something large missed.

The CCP had previously not allowed spike-protein based gene serum technology domestically for mainland Chinese. The CCP had previously allowed the importation of foreign mRNA spike-protein gene serum injections for foreign nationals residing on the mainland.

Until now.

Sinopharm has likely now stolen enough foreign IP to create in-house spike protein based mRNA gene serum injections and are already rolling them into clinical trials.

The National Medical Products Administration has approved the clinical trial for an mRNA Omicron-specific vaccine developed by CNBG-Virogin Biotech (Shanghai) Co Ltd.

It is China's first full-length S-protein-based mRNA vaccine. It is a major breakthrough in mRNA vaccines made by China National Biotec Group (CNBG), a subsidiary of China National Pharmaceutical Group Corporation (known as Sinopharm), said Zhang Yuntao, chief scientist and vice president of CNBG.

The Omicron-targeted vaccine has a higher ability to induce neutralizing antibodies. The company's advanced technologies could enable large-scale production of mRNA-based vaccines encapsulated in lipid nanoparticles, said Jia Weiguo, chief scientist of CNBG-Virogin Biotech.

CNBG-Virogin Biotech has built an intelligent mRNA vaccine production base with an annual capacity of 2 billion vials in Nanxiang, suburban Shanghai.

The company will conduct a highly efficient clinical trial of the vaccine and further examine its safety and protection, it said.

Two billion dose capacity annually.

Chances the clinical trial will fail?

Near zero.

Chances the WHO will approve this new mRNA injection as part of its upcoming “vaccine passport” scheme? Very high.

Why Vaccine Passports Are Not Going Anywhere

Combine this with the upcoming rule changes to the WHO’s International Health Regulations (IHR) and you have a perfect storm for the exportation of these injections to the poor 3rd world — as part of the CCP’s greater, overarching strategy of debt-trap diplomacy.

Next — the CCP (& others like them) will implement vaccine diplomacy.